To clarify whether the mesenchymal cells derived from human placenta were available for bone regeneration, we investigated the effects of osteogenic induction on mesenchymal cells of fetal and maternal parts of the placenta. The osteogenic-induced mineralization in both types of cells was measured by von Kossa staining, and the calcium concentration and the expression of osteogenic markers were assayed by RT-PCR. In the mesenchymal cells of both parts, osteopontin, osteocalcin, alkaline phosphatase, and collagen type I, which are osteogenic markers, were expressed. Moreover, the mesenchymal cells of the fetal part of the placenta were mineralized for 3 weeks, but those of the maternal part were not. These results showed that the mesenchymal cells derived from human placenta had an osteogenic phenotype and that only the mesenchymal cells of the fetal part were capable of being used as a cell source for bone reconstitution.
INTRODUCTION
the onset of mineralization. This protein, characterized by 3γ-carboxy-glutamic acid residues (Gla) that bind Bone as an organ is a complex, highly organized, tightly to hydroxyapatite, is maximally expressed with mineralized tissue that consists of a structural hierarchy mineralization of the ECM (12, 13) . of collagen-based microstructures in association with
The treatment of bone defects is a routine procedure cartilage, hemopoietic and connective tissues. Throughin hospitals. Orthopedic surgeons have gained practical out life, the skeleton is constantly being formed and reexperience in manipulating, pinning, and immobilizing sorbed, events that are necessary for normal skeletal tisbone lesions. These techniques support the natural healsue integrity and maintenance of mineral homeostasis ing processes of bone fractures. In cases of extensive (1, 3) . During progressive development of the bone cell defects, caused by accidents, tumor resection, or by sysphenotype, the temporal sequence of gene expression temic diseases, grafting of autologous bone for repair is has three distinct periods: growth (proliferation) and exa modern applied treatment strategy. Although autolotracellular matrix (ECM) biosynthesis; ECM developgous bone is considered to be the "gold standard" for ment, maturation, and organization; and ECM mineralbone-grafting surgery, major disadvantages are donor ization. During the proliferation period, and fundamental site morbidity, the lack of quality, the quantity of tissue to development of the bone cell phenotype, several that can be harvested, and pain during recovery (10, 16) . genes associated with formation of the ECM (type I col-Therefore, new approaches to bone tissue engineering lagen) are active. After proliferation, alkaline phosphaare being explored. Recently, the most popular approaches tase, protein associated with the bone cell phenotype, is are the use of mesenchymal progenitor and stem cells detected. With onset of mineralization, other bone-related that migrate from the bone marrow or periosteum to the genes are induced; for example, osteopontin and osteomaterial, adhere, expand, and undergo osteogenic differcalcin are increased, paralleling the accumulation of entiation (2, 6) .
minerals. The functions of osteopontin may be related
The placenta is a highly specialized organ whose prito control of relationships between cells and extracellumary function is to promote the exchange of nutrients lar matrices, particularly in light of the Arg-Gly-Aspand oxygen between maternal and fetal blood, essential containing sequence that mediates cell attachment. The for survival and growth of the baby. The placenta has vitamin K-dependent protein, osteocalcin, in contrast to been discarded until recently, despite its abundant volosteopontin, is expressed only postproliferatively with ume of mesenchymal cells (5) . In this study, we exam-338 TAKAHASHI ET AL.
ined whether these cells were available as a cell source stained with 5% silver nitrate solution (w/v) for 1 h under the bright sunlight, rinsed thoroughly with deionized for bone reconstruction. The mesenchymal cells derived from the fetal part of villi in human placenta were min-water, and then fixed with 5% sodium thiosulphate for 5 min. Finally, these layers were counterstained with nu-eralized under osteogenic conditions, but those from the decidua basalis of the maternal part were not.
clear-fast red for 5 min.
MATERIALS AND METHODS

Calcium Concentration Assay Materials
Cell layers were rinsed with PBS(−) and scraped off the dish in 0.5 M HCl. The cell layers were centrifuged Sodium β-glycerophosphate (βGP), ascorbic acid-2at 1000 rpm for 5 min at 4°C. The supernatant was used phosphate (AsAP), a #587 calcium diagnostic kit, and for calcium determination according to the instructions low-glucose Dulbecco's modified essential medium contained in Sigma Kit #587. Absorbance of samples (DMEM) were purchased from Sigma Chemical Co. (St.
was read at 595 nm after the addition of reagents. Total Louis, MO). DNAZOL  , TRIZOL  , random primers, calcium was calculated from standard solutions prepared RNaseOUT TM , and SuperScript TM II were purchased in parallel. from Invitrogen Life Technologies (Carlsbad, CA). Dexamethasone (Dex) was purchased from Wako Chemical DNA Content Assay (Osaka, Japan). Taq DNA polymerase was from Roche
Cell layers were rinsed with PBS(−), lysed with 1.0 Diagnosics GmbH (Mannheim, Germany). Antibiotics, ml of DNAZOL  reagent per 10-cm 2 culture dish. The antimycotics, and 0.25% trypsin/1 mM EDTA solution sediments of lysates were taken away by centrifuging at were from GIBCO, Life Technologies (Grand Island, 12,000 rpm for 15 min at 4°C and the supernatant was NY). Fetal bovine serum (FBS) was purchased from transferred to a fresh tube. DNA was precipitated by addi-Moregate BioTech (Bulimba, Australia). All other roution of 0.5 ml of 100% ethanol per 1.0 ml of DNAZOL  tine reagents were obtained from Wako Chemical (Osaka, reagent used for the isolation. Samples were mixed by Japan).
inversion and stored at room temperature for 3 min. Cell Isolation and Culture DNA pellets were precipitated at 12,000 rpm for 15 min at 4°C and supernatants were discarded. The pellets Specimens of human placenta (n = 3) were obtained were rinsed with 75% ethanol twice. Finally, these pelafter cesarean section performed at 38-40 weeks of geslets were dried and dissolved in 8 mM NaOH. DNA tation with informed consent. The study was approved content was calculated by measuring A 260 and A 280 using by the Internal Review Board of our institute. The fetal a GeneQuant pro spectrometer (Amersham Biosciences villi was taken after the amnion and the chorionic plate Co., Piscataway, NJ). were removed from fetal side of the placenta. The maternal decidua basalis were taken from the pieces of RT-PCR Analysis deciduate placenta. Each tissue was cut into pieces (5 Total RNA was prepared using TRIZOL  and denamm 3 ) and attached to the dishes. Finally, DMEM contured with random primers (15 µg). The cDNA was syntaining 10% FBS and 1% antibiotics/antimycotics was thesized from 4 µg of total RNA in a total volume of 40 added. After 2 or 3 weeks, mesenchymal cells had miµl containing 3 mM MgCl 2 , 75 mM KCl, 50 mM Trisgrated and were then detached using 0.25% trypsin/1
HCl 3′), osteocalcin (sense: 5′-ATGAGAGCCCTCACACTC CTCG-3′; antisense: 5′-CCGGGCCGTAGAAGCGCC GATA-3′), collagen type I (sense: 5′-GGACACAATG GATTGCAAGGT-3′; antisense: 5′-TAACCACTGCT CCACTCTGGG-3′), alkaline phosphatase (liver/bone/ kidney) (sense: 5′-CCCAAAGGCTTCTTCTTGCTG-3′; antisense: 5′-CTGGTAGTTGTTGTGAGCATA-3′), and β-actin (sense: 5′-TGACGGGGTCACCCACACTGTG CC-3′; antisense: 5′-TAGAAGCATTTGCGGTGGAC GATG-3′) were synthesized at System Science (Sapporo, Japan). PCR products were analyzed by agarose gel electrophoresis and visualized by ethidium bromide staining under UV light.
RESULTS
Induction of Mineralization in Mesenchymal Cells Derived From Human Placenta
The mesenchymal cells of the fetal and maternal parts of the placenta were studied for their ability to mineralize the ECM. Mesenchymal cells of the fetal part grown 
Expression of the Osteogenic Potential
alkaline phosphatase plays a role in bone matrix mineralization (15) . In this study, we demonstrated that the in Mesenchymal Cells Derived From Human Fetal and Maternal Parts of Human Placenta mesenchymal cells derived from fetal villi and maternal decidua basalis of human placenta expressed this iso-RT-PCR analysis was performed on total cellular RNA zyme except for the placental one, because RT-PCR extracted from mesenchymal cells derived from fetal analysis was carried out by using its specific primers. and maternal parts of human placenta grown in mainte-Moreover, placental alkaline phosphatase was not exnance medium. mRNAs of osteopontin (OP), osteocalpressed in both mesenchymal cells (data not shown). cin (OC), type I collagen (COL 1), and alkaline phos-However, with the addition of OS to mesenchymal cell phatase (ALP; liver/bone/kidney) were expressed in cultures the fetal part was capable of inducing rapid osmesenchymal cells derived from both the fetal and mateogenesis as defined by the formation of a mineralized ternal parts (Fig. 3) . These expressions were not changed extracellular matrix whereas the maternal part was not after 3 weeks in the fetal mesenchymal cells and the ( Figs. 1 and 2) . Although it was thought that these phematernal mesenchymal cells grown in the maintenance nomena were caused by the differences of protein synmedium (data not shown).
thesis and functions between fetal and maternal mesenchymal cells in osteogenesis, these mechanisms still DISCUSSION remain unclear. The expression level of osteocalcin, This study investigated whether isolated, culturewhich is the maker of the mature osteoblast, was low in expanded mesenchymal cells derived from fetal villi and the fetal and the maternal mesenchymal cells grown in maternal decidua basalis of human placenta could be dithe maintenance medium culture, so it was thought that rected into the osteogenic lineage in vitro, culminating the function of osteocalcin did not work at this point. in mineralized matrix production. These cells expressed Therefore, future experiments are needed. mRNAs of osteopontin, osteocalcin, collagen type I, and
Recently, bone tissue-engineering approaches have alkaline phosphatase, which are osteoblast-related genes attempted to create new bone based on many cell sources (Fig. 3 ). In the human, alkaline phosphatases are classiand scaffolds (11) . The mesenchymal cells from bone fied into four isozymes (4, 14) . It has been shown that marrow have been a major cell source (8, 9) . However, placental alkaline phosphatase is expressed in the plataking bone marrow requires an operation. By contrast, centa (7) , while tissue-nonspecific (liver/bone/kidney) the placenta routinely has been discarded after delivery and little is known about the potential of mesenchymal cells derived human placenta for cell therapy. Recently, efficient adeno-associated virus-mediated gene expression in human placenta-derived mesenchymal cells was reported (17). In the present study, fetal mesenchymal cells derived from placenta were shown to be a possible new cell source of bone regeneration. To clarify their availability, it is necessary to conduct further detailed experiments.
